Generic APIs

Polpharma Fine Chemicals Business Unit is building its strong position as an active supplier of generic APIs on the global market. The company strives to become a leading player in this market segment.

Our current API offer includes:

• Acetazolamide, Acetylsalicylic acid, Acyclovir, Alendronate sodium and Aripiprazole
• Baclofen, Bupropion hydrochloride
• Carbamazepine, Carvedilol, Carvedilol phosphate, Chlorpropamide, Cholecalciferol, Clopidogrel bisulphate and Cyclobenzaprine hydrochloride
• Darifenacin hydrobromide, Diclofenac sodium and Doxercalciferol
• Enalapril maleate, Entacapone, Ethenzamide and Etodolac
• Hydrochlorothiazide
• Ibandronate sodium
• Lamotrigine
• Metoclopramide hydrochloride, Metoprolol succinate, Metoprolol tartrate, Metronidazole and Montelukast sodium
• Opipramol dihydrochloride
• Pentoxifylline, Phenyl salicylate and Piracetam
• Repaglinide, Risedronate sodium and Rosuvastatin calcium,
• Salicylamide, Sildenafil base, Sildenafil citrate, Sodium salicylate, Sulfadimethoxine and Sulfadimethoxine sodium
• Tadalafil, Tinidazole, Tolbutamide, Tolterodine and Topiramate
• Vardenafil hydrochloride
• Zoledronic acid

Current API development pipeline:

Adavnced stage Bosentan, Irbesartan, Iron polymaltose, Magnesium aspartate, Paricalcitol, Pregabalin, Rasagiline, Valacyclovir hydrochloride, Ziprasidone hydrochloride Early development / evaluation stage Aliskiren hemifumarate, Arzoxifene, Dabigatran etexilate, Fondaparinux sodium, Glatiramer acetate, Prasugrel, Retigabine, Rivaroxaban, Saxagliptin, Tapentadol, Varenicline, Vildagliptin

For a complete product list please visit our website.